Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke

NCT03993236 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

584

Enrollment

OTHER

Sponsor class

Conditions

Stroke, Ischemic

Interventions

DRUG: Experimental: Rosuvastatin/Ezetimibe 10
DRUG: Active Comparator: Rosuvastatin 20mg

Sponsor

Keun-Sik Hong

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]